Nalaganje...
Antiplatelet Therapy for Stroke Prevention in Atrial Fibrillation
Warfarin has been the cornerstone therapy for stroke prevention in non-valvular atrial fibrillation (NVAF), particularly in patients at high risk of ischemic stroke or thromboembolism. Warfarin use in NVAF results in a 64% relative reduction in the incidence of ischemic stroke and several trials hav...
Shranjeno v:
| izdano v: | Mo Med |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Journal of the Missouri State Medical Association
2010
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6192815/ https://ncbi.nlm.nih.gov/pubmed/20222295 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|